- Home
- MRK vs TD Comparison
MRK vs TD Comparison
Compare MRK & TD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | TD |
|---|---|---|
| Founded | 2000 | 1855 |
| Country | United States | Canada |
| Employees | N/A | 102218 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 160.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | TD |
|---|---|---|
| Price | $114.99 | $95.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $124.29 | $120.00 |
| AVG Volume (30 Days) | ★ 7.6M | 1.6M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | 2.95% | ★ 3.19% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.47 | $4.22 |
| P/E Ratio | $15.83 | ★ $11.65 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $54.87 |
| 52 Week High | $125.14 | $99.84 |
Technical Indicators
Market Signals| Indicator | MRK | TD |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 48.15 |
| Support Level | $113.82 | $93.09 |
| Resistance Level | $125.14 | $96.41 |
| Average True Range (ATR) | 2.78 | 1.92 |
| MACD | -1.02 | -0.43 |
| Stochastic Oscillator | 12.72 | 31.95 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.